Chronic granulomatous disease (CGD) is characterized by the failure of phagocytic leukocytes to kill certain bacteria and fungi. This is caused by deficiencies in one of the components of NADPH oxidase, the enzyme in phagocytic leukocytes that generates superoxide. In a rare, autosomal recessive form of CGD, a 67-kD cytosolic component of NADPH oxidase (p67-phox) is missing. Until now, mutations in the gene coding for this protein have not been identified. We now report on a 1 0-year-old girl with lymph node and liver abscesses who was recognized as an A67' CGD patient by lack of NADPH oxidase activity in her granulocytes, a cytosolic defect in a cell-free oxidase system, and lack of immunoreactive material with an antiserum against the p67-phox protein. mRNA for this protein was present HRONIC GRANULOMATOUS disease (CGD) is a rare syndrome clinically characterized by recurrent, life-threatening pyogenic infections, with bacteria and fungi, of subcutaneous tissues, upper airways, lungs, bones, spleen, liver and lymph nodes.' This disease is caused by the inability of the patients' phagocytes (neutrophilic granulocytes, eosinophilic granulocytes, monocytes, and macrophages) to generate superoxide, a precursor of reactive oxygen metabolites essential for the killing of various microorganisms. In normal phagocytes, the enzyme NADPH oxidase starts to produce superoxide when the cells are activated, eg, by phagocytosis of microorganisms. This enzyme is composed of several subunits, some of which are localized in the plasma membrane and others (in resting cells) in the cytosol.* During phagocytosis, the cytosolic components translocate to the plasma membrane and integrate with the membrane-bound components into an enzymatically active complex. Defects in any of the four NADPH oxidase components cause inactivity of the enzyme, thus leading to CGD.3
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type of CGD (A47' CGD),3.6.7 with an estimated incidence of about 30%. Finally, absence of the 67-kD protein (p67-phox) is found in the rare A67' subtype of CGD,3,8,9 constituting about 5% of the patients. Although the mRNA nucleotide sequence of p67-phox has been published," mutations in patients with A67' CGD have not been reported so far.
We have now identified for the first time a mutation in p67-phox in a patient with A67' CGD. Moreover, two polymorphisms in the p67-phox mRNA are described.
CLINICAL HISTORY
N.K., a girl, was born in 1982 after an uneventful delivery from nonconsanguineous, healthy parents. An older brother of N.K. died at the age of 6 years from bilateral pneumonia with a history of recurrent lymph node abscesses and failure to thrive. At autopsy, multiple granulomas and pigmented histiocytes were found. N.K. had disseminated pyoderma after birth. After two cervical lymph node abscesses at 13 and 2 l months ofage, and a single liver abscess (right lobe) at 33 months of age, the diagnosis of CGD was confirmed in the dystrophic child by completely absent nitroblue tetrazolium (NBT) reduction and Oi formation by her granulocytes. Under continuous cotrimoxazole prophylaxis, no further infections 532 DE BOER ET AL occurred; recombinant human y-interferon was administered at a dose of 50 pg/m2 3 times per week subcutaneously for I year, but then had to be stopped for discomfort.
MATERIALS AND METHODS
Purification of granulocytes. Blood was drawn in acid-citratedextrose (USP formula A) and transported at ambient temperature. Within 6 hours after blood collection, granulocytes were purified as described previously." Granulocytes (>90% neutrophils and 2% to 10% eosinophils) were suspended in incubation medium (132 mmol/L NaCI, 6 mmol/L KCI, Functional tests. The NBT slide test was performed as previously described.12 From each donor, 400 cells stained with nuclear fast red were examined and scored as formazan-negative or formazan-positive.
Superoxide generation was measured by cytochrome c reduction of granulocytes ( 106/mL) in incubation medium containing 60 pmol/L femcytochrome c and 2 mmol/L azide.13 Maximal rates of cytochrome c reduction were determined in a Perkin Elmer spectrophotometer (model Lambda 2; Perkin Elmer, Nonvalk, CT). The contents of each cuvette (0.8 mL) were stirred and kept at 37°C.
When combinations of stimuli were used (Table l) , the second stimulus was administered about 3 minutes after the first stimulus. Maximal rates of cytochrome c reduction were measured after each addition. Further details are found in Verhoeven et al."
The NADPH oxidase activity was also measured in the cell-free activation system.I4 Purified plasma membranes (6 pg of protein) and cytosol ( I 20 pg of protein) from sonicated granulocytes were incubated at 28°C in 800 pL of oxidase buffer containing 75 pmol/ L NaCI, 10 mmol/L HEPES, I pmol/L MgCI2, 0.5 pmol/L EGTA, 60 pmol/L ferricytochrome, 2 mmol/L azide, and 10 pmol/L GTPy-S (pH 7.0). The assembly of oxidase components was initiated by the addition of 20 pL of sodium dodecyl sulfate (SDS) to a final concentration of 100 pmol/L. Three minutes later, NADPH was added to a final concentration of 250 pmol/L. The NADPH oxidase activity was determined after the slope of the absorbance change at 550 nm had become constant (between 1 and 2 minutes after NADPH addition).
Determination of' NADPH oxidase components. Cytochrome bSss heme spectrum was measured in a Triton X-100 lysate of granulocytes as described previo~sly.'~ The presence ofcytochrome bsss on the surface of intact cells was determined by fluorescence-activated cell sorter (FACS) analysis after binding of monoclonal antibody 7D5I6 and fluorescein isothiocyanate (FITC)-conjugated goatantimouse Ig.
The presence of p47-phox and p67-phox was determined on Western blots with antisera specific for either p47-phox or p67-phox. These antisera were obtained after immunization of rabbits with synthetic peptides coupled to KLH, containing the C-terminal part of these proteins (SESTKRKLASAV and ATTLESTRREV, respectively).
Preparation ($RNA and DNA. Mononuclear leukocytes were purified from 20 to 100 mL of citrated blood by isopycnic centrifugation for 20 minutes at 1,OOOg at 20°C on an isotonic Percoll suspension (Pharmacia Fine Chemicals, Uppsala, Sweden) with a specific gravity of 1.076 g/mL. The cell layer on top of the Percoll suspension was collected and washed twice with phosphate-buffered saline (PBS). The number of monocytes was calculated from a sizedistribution pattern (Coulter Counter; Coulter, Hialeah, FL). RNA was isolated by dissolving the mononuclear cells in 4 mol/L guanidine thiocyanate and by centrifugation through 5.7 mol/L cesium chloride." Genomic DNA was isolated from circulating blood leukocytes."
Cloning o/p6 7-phox cDNA. RNA was obtained from mononuclear leukocytes of six healthy donors. This RNA was reverne transcribed, and the cDNA of p67-phox was amplified by PCR in one fragment, using primers 1 and 6 (Table 2) and VentR DNA polymerase (Biolabs New England, Beverly, MA) according to the manufacturer's recommendations. The polymerase chain reaction (PCR) product was digested with EcoRI and Hind111 and cloned in the PGEX-2T expression vector. The sequence of the product was identical to that reported by Leto et a1,''except for a G at nucleotide position 983 instead ofthe published A-983 (see Results).
Northern blot analysis. RNA corresponding to IO' monocytes The lowercase letters indicate EcuRI, BamHI, and Hindlll restriction sltes to facilitate cloning of the PCR fragments. Primers 7 through 12 are nested primers that were used in a second, nested PCR together with primers 1 through 6, respectively. * Antisense primer.
For
MUTATION IN A p67-DEFICIENT CGD PATIENT
was submitted to electrophoresis in 1.2% (wt/vol) agarosegcls in thc presence of formaldehyde and was blotted onto GcncScrcen Plus membrane filters." Blots were hybridized with a p67-pl10,v cDNA probe containing the total coding rcgion and labeled by random priming. Hybridization with a probe for m-actin was used as a control for the quantification and intcgrity of the RNA.
Arnp/$cu/ion und .scJ4r1cncing c?/DA!4. For analysis of mRNA sequences. first-strand cDNA was synthesized from mononuclear cell RNA. The p67-p/10.r cDNA coding rcgion was amplified by PCR in six overlapping fragments under conditions described by Bolscher et al. " The oligonucleotide primers arc listcd in Table 2 . For PCR amplification of fragments I and 2. primcrs I and 2 were used. followed by nestcd PCR with primers I and 7 (fragment I )and primers2 and 8 (fragment 2). The other fragmentswcre amplified in a similar way (see legend to Table 2 ). The PCR products were purified with the Geneclcan I1 kit (BIO 101. Inc. La Jolla. CA) to remove the primers and nucleotides. Two hundred nanograms of the purified DNA samples was anncaled with 40 ng of one of the primers used for amplification by first being heated for 3 minutes at 100°C and then being chilled on ice water in thc presence of 10% dimethylsulfoxide. Direct sequence analysis was performed with the Sequenase version 2.0 kit (US Biochemical Corp. Cleveland. OH). In genomic DNA. the mutations were identified in a similar way.
/'~~/~~~torphi.sr,rs. The mutation found in thc patient and her relatives was excluded from being a polymorphism with the restriction enzyme Fok I (Biolabs) acting on a 103-bp PCR fragment from genomic DNA containing exon 3 plus boundary sequcnces (primers I3 and 14, Table 2 ). All control alleles were cleaved into fragments of 82 + 25 bp. whereas the PCR figment obtained from genomic DNA of the patient remained intact. In the material from the patient's relatives. the original fragment as well as the cleavage products were dctected.
Similarly, the frequency of one polymorphism found at nucleotide position 983 and one difference with thc published sequence at nucleotide position 895 (numbered with respect to the published cDNA sequence") was determined in a similar way by PCR amplification of exon I I (96 bp: primers 17 and 18) and exon 10 (91 bp: primers I5 and 16) and cleavage by thc restriction cnzymes Bhs I (23 + 77 bp) and Rs/7 I I (40 + 55 bp). respectively.
RESULTS
Identijcicntion of ,/le CGD subtype. The patient was identified as a CGD patient by complete lack of NBT reduction by her granulocytes with either phorbol myristate acetate (PMA) or serum-treated zymosan (STZ) as the stimulus. In contrast. the mother showed a completely normal NBT slide test. Superoxide production measured by cytochrome c reduction was also totally absent in the patient's granulocytes stimulated with either PMA or PMA + fMLP.
To exclude a cytochrome hSsR deficiency as the cause of the disease, the heme content of the granulocytes was measured. The patient showed a value of 5.4 pmol/106 cells and her mother 6.7 pmol/106 cells (normal range. 6.3 to 7.5 pmol/106 cells, n = 6). In the FACS assay with monoclonal 7D5,99.9% of the patient's granulocytes were shown to express cytochrome hSsx at the cell surface (mother, 99.9%: normal range. 98.5'70 to 99.9%: n = IO).
In the cell-free activation system. the cytosol of the patient's granulocytes did not support NADPH oxidase activity of membranes from an A47" CGD patient (0. I pmo102/ min), whereas cytosol from normal granulocytes did (7.8 pmol 02/min). However, the addition of 40 pg of p67-p/m- protein purified from normal neutrophil cytos01'~ corrected the reaction of the patient's cytosol to 5.9 pmol Odmin.
On Western blots after SDS polyacrylamide gel electrophoresis, p47-p/io.u was clearly present in the granulocyte cytosol from the patient. but p67-ph0,~ was not detectable (Fig l ) . Thus. the patient suffers from the A67" subtype of CG D.
Ichwtificution (!fthc nmtution. The mRNA of the patient's monocytes contained p67-pho.u mRNA, as detected on Northern blot (not shown). mRNA ofapparently normal size and amount (in comparison to e-actin p67-phox mRNA) was found. The p67-phm mRNA of the patient was converted to cDNA and amplified in six overlapping fragments. Electrophoresis on agarose gel showed that the amplified fragments from the patient had a size similar to that of fragments obtained from normal control cells. Sequence analysis of the first fragment showed a G-233 + A transition, predicting a nonconservative "Gly + Glu substitution (Fig 2) . The other PCR fragments had the same composition as those of control cells. The G-233 + A mutation was also found in the genomic DNA of the patient. as shown in a PCR-amplified fragment of exon 3 plus boundary sequences (Fig 3) . We observed the normal nucleotide sequence neither in the cDNA nor in the genomic cDNA of the patient. Thus, the patient appears to be homozygous for this mutation. Both parents and the sister of the patient were found to be heterozygotes for this mutation (Fig 3) . To investigate whether this mutation represents a polymorphism, PCR fragments obtained from genomic DNA, containing exon 3 plus boundary sequences, were subjected to Fok I restriction enzyme digestion (see the Materials and Methods). The results again showed the patient to be homozygous for the mutation and the family members to be carriers. However, this mutation was not found in 38 normal donors, rendering it unlikely that the G-233 + A mutation is polymorphic. We found one polymorphism, ie, at A-983 G, changing AAA (coding for lysine) into AGA (coding for arginine). The frequency of this polymorphism was established by restriction enzyme analysis (see the Materials and Methods). Of 38 normal donors tested, none was homozygous for A-983,36 were homozygous for G-983, and 2 were heterozygous for both nucleotides.
Moreover, in contrast to the published sequence," we found in 38 normal donors C-895 instead of T-895. This mutation changes TTG into CTG, both coding for 2991eu-cine. Probably, this is also a polymorphism, .because T-895 was found in multiple clones from a cDNA library and in a genomic library from a different person."
Carrier detection. The camer state of the family members was also detectable in the NADPH oxidase activity of their neutrophils. The oxygen consumption (not shown) and the superoxide production ( Table 1 ) of these cells after activation with PMA was only 25% to 50% of normal. However, when activated by FMLP subsequently to PMA, the cells displayed a normal oxygen consumption (not shown) and 60% to 65% of the normal superoxide production (Table l). Similarly, with STZ (not shown) or cytochalasin B (CB) plus FMLP, the cells showed 80% to 100% of normal NADPH oxidase activity (Table I) . Apparently, p67-phox is only rate-limiting for the NADPH oxidase activity of intact neutrophils when the cells are activated with PMA.
In the cell-free activation system, activated by SDS in the presence ofGTP-7-S, the heterozygous state was also clearly detectable ( Table I) .
DISCUSSION
CCD caused by a mutation in the NCF-2 gene encoding p67-phox is extremely rare, probably causing less than 5% of all known cases of CCD. Until now, only five A67' CCD patients have been reported in the literat~re.~"~*'~ In each of these, mRNA was present at apparently normal size and amount, whereas protein detectable on Western blot with specific antisera against p67-phox was ~ndetectable.~-~~*'~ The gene structure of NCF-2 has recently been published in detail." We are now able to identify the mutation that most probably causes the instability of p67-phox in one previously unreported A67' CGD patient. Remarkably, this patient was found to be homozygous for a G-233 + A missense mutation, although the parents are not known to be related to each other. Nevertheless, this mutation was found in all family members but not in the genomic DNA of 38 control individuals.
The G-233 + A mutation predicts a nonconservative 78Gly -P Glu replacement. How this amino acid change decreases the stability of the p67-phox protein is not known. It has been reported" that p67-phox is present in the cytosol of resting neutrophils in a complex with p47-phox. Perhaps the 78Gly "t Glu replacement has affected the binding site on p67-phox for p47-phox, thus decreasing the stability of the p67-phox protein. Decreased protein stability caused by one amino acid replacement has also been found in other components of the NADPH o~i d a s e . '~,~~~~~
The functions of 47-phox and p67-phox are not known. Recently, indications have been found that cytochrome bSs8 may be a flavocyt~chrorne.~.~ Thus, this protein may be both the acceptor of electrons from NADPH and the donor of electrons to molecular oxygen. If this is true, cytochrome bSs8 may be the NADPH oxidase sensu stricto, and p47-phox and p67-phox may be activity-regulating proteins of this enzyme, together with one or more low molecular weight GTP-binding proteins.24325 It is known that p47-phox and p67-phox translocate to cytochrome b558 in the plasma membrane on activation of neutrophils. This translocation may be induced by phosphorylation of p47-phox in intact cells26 and by SDS or arachidonic acid in the cell-free system,*' but the details of this process and the regulation of NADPH oxidase activity are not yet known. Thus, it is impossible to even speculate on the need for p67-phox in this regulatory process.
In neutrophils with subnormal amounts of p67-phox, we found that this protein is rate-limiting for NADPH oxidase activity only under certain conditions. When PMA was used as the activating agent, carriers for the p67-phox deficiency were easily detected, but with other (combinations of) agents this proved to be impossible. In control neutrophils, PMA induced already near-maximal rates of oxygen consumption, whereas in neutrophils from A67' CGD carriers, this rate was significantly enhanced by subsequent addition of FMLP. Similar results were previously obtained with neutrophils from autosomal CGD carriers," later identified as A47' CGD camers (De Boer and Roos, unpublished results). Perhaps phosphorylation of p47-phox by protein kinase C (activated by PMA) is a relatively weak signal for p47-phox and p67-phox translocation to cytochrome b558.
FMLP and STZ, which may induce this reaction through another signal transduction p a t h~a y ,~~. '~ may be stronger stimuli of this reaction. In this way, FMLP and STZ might be able to induce normal NADPH oxidase activity in the presence of decreased amounts of p47-phox or p67-phox.
The mutations found in X91' CGD and in A22' CGD are very heterogeneous, whereas those found in A47' CGD always involve one particular dinucleotide deletion, in either one or both alleles. 22 In addition, only four polymorphisms have been detected in ~22-phox,*~ none at all in gp91-phox, but at least a dozen in p47-phox (S. Chanock, personal communication, December 1992). In p67-phox, two polymorphisms have now been recognized, of which one is silent. Apparently cytochrome b5,, is a protein in which nearly all amino acids are critical for its stability and/ or function, whereas p47-phox and perhaps also p67-phox are less sensitive in this respect.
